Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Caribou Biosciences Inc shares valued at $20,400 were purchased by Haurwitz Rachel E. on Mar 14 ’25. At $1.02 per share, Haurwitz Rachel E. acquired 20,000 shares. The insider’s holdings grew to 3,369,395 shares worth approximately $4.78 million following the completion of this transaction.
Also, MCCLUNG BARBARA G sold 3,564 shares, netting a total of over 4,811 in proceeds. Following the sale of shares at $1.35 each, the insider now holds 443,502 shares.
Before that, Khan Ruhi Ahmad had sold 3,564 shares from its account. In a trade valued at $4,811, the Chief Business Officer traded Caribou Biosciences Inc shares for $1.35 each. Upon closing the transaction, the insider’s holdings decreased to 3,564 shares, worth approximately $95049.12.
As published in a research note from Evercore ISI on June 03, 2024, Caribou Biosciences Inc [CRBU] has been rated down from an Outperform to an In-line and the price target has been revised to $3 from $13. Analysts at Cantor Fitzgerald started covering the stock with ‘”a Neutral”‘ outlook in a report released in early November. As of October 31, 2023, Evercore ISI has initiated its “an Outperform” rating for CRBU. Earlier on July 11, 2023, Truist initiated its rating. Their recommendation was “a Buy” for CRBU stock.
Analyzing CRBU Stock Performance
On last trading session,, Caribou Biosciences Inc [NASDAQ: CRBU] rose 0.71% to $1.42. The stock’s lowest price that day was $1.3446, but it reached a high of $1.43 in the same session. During the last five days, there has been a surge of approximately 22.41%. Over the course of the year, Caribou Biosciences Inc shares have dropped approximately -17.44%. Shares of the company reached a 52-week high of $2.0400 on 01/07/25 and a 52-week low of $0.6600 on 04/07/25.
Support And Resistance Levels for Caribou Biosciences Inc (CRBU)
According to the 24-hour chart, there is a support level at 1.3664, which, if violated, would cause prices to drop to 1.3128. In the upper region, resistance lies at 1.4518. The next price resistance is at 1.4836. RSI (Relative Strength Index) is 68.41 on the 14-day chart, showing neutral technical sentiment.
Is Caribou Biosciences Inc subject to short interest?
Stocks of Caribou Biosciences Inc saw a sharp rise in short interest on 2025-05-30 jumping by 0.71 million shares to 8.34 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 7.63 million shares. A jump of 8.47% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.98 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.98.
Which companies own the most shares of Caribou Biosciences Inc (CRBU)?
In terms of Caribou Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 3 in the next 12 months, up nearly 112.77% from the previous closing price of $1.41. Analysts anticipate Caribou Biosciences Inc stock to reach 3 by 2025, with the lowest price target being 3. In spite of this, 3 analysts ranked Caribou Biosciences Inc stock as Buy at the end of 2025. On February 18, 2022, RBC Capital Mkts assigned a price target of “an Outperform” to the stock and initiated coverage with a $22.
